Search
  • Language
    • search
    Language

    Who are we

    Group Introduction

    China National Pharmaceutical Group Co Ltd (Sinopharm) is a centrally-administered State-owned enterprise under the direct management of the State-owned Assets Supervision and Administration Commission of the State Council (SASAC).Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. With a primary focus on life & health, the company owns a complete industrial chain covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering technology, exhibitions and events, international business and financial services.
    Learn more

    Company Profile

    Sinopharm International is a wholly-owned subsidiary of Sinopharm, which dedicates to be a technology-driven global enterprise that is leading domestically while influential internationally and constantly meet people's needs for a healthy and better life. With a registered capital of 5 billion yuan, Sinopharm International covers international operations, nutrition and health, tax-free business and health care. In 2021, the sales revenue of Sinopahrm International reached RMB 59.2 billion, with an excellent import and export volume of USD 7.6 billion. 

    • 5
      Registered capital（Billion Yuan）
    • 59.2 +
      Sales Revenue in 2021（Billion Yuan）
    • 7.6 +
      Import and Export Volume（Billion USD）
    • 195
      Countries,regions and international organizations in partnership
    Learn more

    Development

    • 1980
    • 1981
    • 1989
    • 2010
    • 2024

    • 2024

      Sinopharm International is a wholly-owned subsidiary of Sinopharm, which dedicates to be a technology-driven global enterprise that is leading domestically while influential internationally and constantly meet people's needs for a healthy and better life. With a registered capital of 5 billion yuan, Sinopharm International covers international operations, nutrition and health, tax-free business and health care. In 2021, the sales revenue of Sinopahrm International reached RMB 59.2 billion, with an excellent import and export volume of USD 7.6 billion.

    Responsibility

    Sinopharm International always adheres to the principle of putting people and their lives first, firmly upholds its aspiration of all for health and health for all, actively performs the political, economic and social responsibilities of a central enterprise, firmly establishes and practices the new development concept, and unswervingly pursues the harmony and progress between enterprises and society, people and nature.

    Learn more

    Sinopharm Stores

    Sinopharm Stores

    Healthy Essentials, Selected by Sinopharm, Shopping Globally